Noxafil (posaconazole delayed-release tablets [generic], oral suspension [generic], PowderMix for delayed-release oral suspension - Merck) — Cigna
Fungal Infection (Systemic) in a Patient With Cancer and Neutropenia – Prophylaxis
Initial criteria
- Patient has cancer with neutropenia (e.g., myelodysplastic syndrome, acute myeloid leukemia, post-allogeneic hematopoietic cell transplant)
- Requires prophylaxis for systemic fungal infection
Approval duration
6 months